As the inflammation of the urinary bladder induced a marked elevation in the number of bladder afferents expressing GAL [3,63], the possible increase in SP release from afferent terminals of the bladder wall after GUA treatment can lead to overexpression of GAL in DRG-UBPNs by triggering the neurogenic inflammation. This evidence concerns the gene GAL and urogenital neoplasm.